Here's the live share price of Dr. Reddy's Laboratories along with daily highs, lows, percentage changes and volume trends, and, all financial information.
Over the last 5 years, the share price of Dr. Reddy's Laboratories has gained 3.93% CAGR. Over the past year, the corresponding return has been -6.32%.
Dr. Reddy's Laboratories’s current P/E of 18.14x helps give context to how the market is valuing the stock based on recent earnings and growth expectations. Check out if this stock is part of our Best Pharmaceuticals and Healthcare Stocks Screener.
Name | 1W(%) | 1M(%) | 3M(%) | 6M(%) | 1Y(%) | 3Y(%) | 5Y(%) |
---|---|---|---|---|---|---|---|
Dr. Reddy's Laboratories | 1.27 | -2.42 | -0.59 | 15.24 | -5.37 | 12.94 | 4.14 |
Sun Pharmaceutical Industries | 0.59 | 3.18 | -1.28 | -0.38 | -14.78 | 20.25 | 26.24 |
Divi's Laboratories | 7.96 | 2.75 | -11.82 | 14.51 | 2.97 | 18.77 | 14.11 |
Cipla | -0.03 | -2.48 | 1.45 | 6.86 | -9.97 | 10.54 | 13.48 |
Torrent Pharmaceuticals | -0.64 | -2.80 | 5.54 | 13.23 | -0.52 | 30.47 | 20.40 |
Mankind Pharma | 1.04 | -4.85 | -2.43 | 6.47 | -8.30 | 20.05 | 11.59 |
Zydus Lifesciences | 1.08 | -3.30 | 2.47 | 18.69 | -5.89 | 33.09 | 18.04 |
Lupin | -0.35 | 0.81 | 3.23 | 2.79 | -13.54 | 40.86 | 13.94 |
Alkem Laboratories | 0.79 | 3.22 | 14.51 | 13.75 | -12.51 | 20.07 | 15.13 |
Aurobindo Pharma | 2.65 | 6.89 | -2.44 | 5.63 | -26.15 | 27.67 | 5.96 |
Abbott India | -0.41 | -2.91 | -13.39 | 2.11 | 4.06 | 16.53 | 13.13 |
Glenmark Pharmaceuticals | -0.67 | -8.07 | 7.02 | 41.30 | 8.81 | 70.36 | 31.65 |
Biocon | 1.56 | -3.50 | -5.75 | 15.30 | 1.38 | 8.25 | -4.85 |
GlaxoSmithKline Pharmaceuticals | 2.63 | -1.88 | -16.21 | 3.38 | -1.65 | 25.68 | 12.15 |
Laurus Labs | -2.21 | -5.49 | 7.43 | 51.36 | 88.16 | 18.19 | 21.16 |
Anthem Biosciences | 0.30 | -5.48 | 5.98 | 5.98 | 5.98 | 1.96 | 1.17 |
Ipca Laboratories | 1.20 | 1.86 | -7.59 | 3.66 | -16.60 | 13.76 | 4.98 |
Cohance Lifesciences | 1.63 | -13.24 | -10.29 | -15.91 | -26.62 | 28.17 | 18.21 |
Gland Pharma | -1.54 | 1.60 | 3.83 | 39.97 | 14.76 | -1.59 | 1.43 |
Ajanta Pharma | 0.86 | -5.63 | -7.84 | -1.97 | -28.23 | 24.04 | 18.15 |
Over the last one year, Dr. Reddy's Laboratories has declined 5.37% compared to peers like Sun Pharmaceutical Industries (-14.78%), Divi's Laboratories (2.97%), Cipla (-9.97%). From a 5 year perspective, Dr. Reddy's Laboratories has underperformed peers relative to Sun Pharmaceutical Industries (26.24%) and Divi's Laboratories (14.11%).
Day | SMA | EMA |
---|---|---|
5 | 1,243.14 | 1,244.21 |
10 | 1,258.58 | 1,253.67 |
20 | 1,283.61 | 1,264.45 |
50 | 1,265.43 | 1,267.65 |
100 | 1,273.17 | 1,261.21 |
200 | 1,243.75 | 1,253.16 |
Fund Name | No. Of Shares | % of AUM | Amount Invested(in ₹ crore) |
---|---|---|---|
Parag Parikh Flexi Cap Fund | 1,16,32,943 | 1.27 | 1,465.87 |
SBI Nifty 50 ETF | 1,09,81,913 | 0.69 | 1,383.83 |
ICICI Prudential Value Discovery Fund | 93,22,942 | 2.19 | 1,174.78 |
Nippon India Large Cap Fund | 53,57,429 | 1.5 | 675.09 |
ICICI Prudential Balanced Advantage Fund | 48,86,509 | 0.94 | 615.75 |
ICICI Prudential Pharma Healthcare & Diagnostics (P.H.D) Fund | 46,33,059 | 9.47 | 583.81 |
Nippon India Pharma Fund | 39,16,074 | 5.9 | 493.46 |
ICICI Prudential Bluechip Fund | 36,55,647 | 0.64 | 460.65 |
Mirae Asset Large & Midcap Fund | 36,44,961 | 1.15 | 459.3 |
UTI Nifty 50 ETF | 34,43,108 | 0.69 | 433.87 |
Price | (%) As on Invalid Date IST |
Open Interest | (%) |
High | |
Low | |
Open | |
Close | |
Contract Traded | |
Turnover (in lakhs) |
Date Time | Announcement |
---|---|
Sep 22, 2025, 11:13 PM IST | Dr. Reddy's Labs - Announcement under Regulation 30 (LODR)-Press Release / Media Release |
Sep 22, 2025, 9:27 PM IST | Dr. Reddy's Labs - Board Meeting Intimation for Approval Of The Unaudited Standalone And Consolidated Financial Results Of Th |
Sep 16, 2025, 10:41 PM IST | Dr. Reddy's Labs - Announcement under Regulation 30 (LODR)-Press Release / Media Release |
Sep 15, 2025, 5:05 PM IST | Dr. Reddy's Labs - Announcement under Regulation 30 (LODR)-Allotment of ESOP / ESPS |
Sep 04, 2025, 11:45 PM IST | Dr. Reddy's Labs - Disclosure Under Regulation 30 Of The SEBI (Listing Obligations And Disclosure Requirements)Regulations, 2 |